Niperotidine
Niperotidine[edit]
Niperotidine is a histamine H2 receptor antagonist that was developed for the treatment of peptic ulcer disease and other conditions where reduction of gastric acid secretion is beneficial. It belongs to the class of drugs known as H2 antagonists, which work by blocking the action of histamine on the parietal cells in the stomach, thereby decreasing the production of stomach acid.
Mechanism of Action[edit]
Niperotidine functions by selectively inhibiting the H2 receptors located on the gastric parietal cells. This inhibition prevents the binding of histamine, a compound that stimulates acid secretion. By blocking this pathway, niperotidine effectively reduces both basal and stimulated gastric acid secretion, which is beneficial in the management of conditions like gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome.
Clinical Use[edit]
Niperotidine was investigated for its potential use in treating conditions such as:
However, its development was halted due to concerns over hepatotoxicity, which is the potential of causing liver damage. This adverse effect limited its clinical application and led to the discontinuation of its development.
Adverse Effects[edit]
The primary concern with niperotidine was its potential to cause liver damage. Other possible side effects, similar to those seen with other H2 antagonists, might include:
